PFKP and cancer: Importantly, we demonstrated concomitantly high expression of USP5 and PFKP in TNBC patients with advanced TNM stage (Fig. 6c), highlighting that dysregulated USP5-PFKP signaling was functionally linked to cancer progression in TNBC.